AI Article Synopsis

  • The study investigates hematopoietic stem and progenitor cells (HSPCs) in cord blood from preterm and term neonates, focusing on their concentration, clonogenic capacity, and the effects of various maternal and perinatal factors.
  • Findings revealed that preterm cord blood has a higher concentration of CD34+ HSPCs and greater clonogenic potential than term cord blood, with maternal age, gestational age, and white blood cell count influencing HSPC levels.
  • The research suggests that preterm cord blood's enhanced HSPC properties may open new opportunities for autologous stem cell therapies in neonates.

Article Abstract

Background: In the last decades, human full-term cord blood was extensively investigated as a potential source of hematopoietic stem and progenitor cells (HSPCs). Despite the growing interest of regenerative therapies in preterm neonates, only little is known about the biological function of HSPCs from early preterm neonates under different perinatal conditions. Therefore, we investigated the concentration, the clonogenic capacity and the influence of obstetric/perinatal complications and maternal history on HSPC subsets in preterm and term cord blood.

Methods: CD34+ HSPC subsets in UCB of 30 preterm and 30 term infants were evaluated by flow cytometry. Clonogenic assays suitable for detection of the proliferative potential of HSPCs were conducted. Furthermore, we analyzed the clonogenic potential of isolated HSPCs according to the stem cell marker CD133 and aldehyde dehydrogenase (ALDH) activity.

Results: Preterm cord blood contained a significantly higher concentration of circulating CD34+ HSPCs, especially primitive progenitors, than term cord blood. The clonogenic capacity of HSPCs was enhanced in preterm cord blood. Using univariate analysis, the number and clonogenic potential of circulating UCB HSPCs was influenced by gestational age, birth weight and maternal age. Multivariate analysis showed that main factors that significantly influenced the HSPC count were maternal age, gestational age and white blood cell count. Further, only gestational age significantly influenced the clonogenic potential of UCB HSPCs. Finally, isolated CD34+/CD133+, CD34+/CD133- and ALDH(high) HSPC obtained from preterm cord blood showed a significantly higher clonogenic potential compared to term cord blood.

Conclusion: We demonstrate that preterm cord blood exhibits a higher HSPC concentration and increased clonogenic capacity compared to term neonates. These data may imply an emerging use of HSPCs in autologous stem cell therapy in preterm neonates.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152327PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0106717PLOS

Publication Analysis

Top Keywords

cord blood
24
clonogenic potential
16
preterm cord
16
preterm term
12
preterm neonates
12
clonogenic capacity
12
term cord
12
gestational age
12
preterm
10
hspcs
9

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!